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legal issues in medicine
 
The Right to Health and the Nevirapine Case in South Africa
 
George J. Annas, J.D., M.P.H.
 
Thanks to activists in South Africa, the right to health
as a human right has returned to the international
stage, just as it was being displaced by economists
who see health through the prism of a globalized
economy and by politicians who see it as an issue
of national security or charity. The current post-apart-
heid debate in South Africa is not about race but
about health, and in this context, the court victory
by AIDS activists in the nevirapine case has been
termed not only, as stated in one British newspaper,
“the greatest defeat for [President Thabo] Mbeki’s
government” but also the opening of “legitimate
criticism” of the government “over a host of issues





the nevirapine case as a centerpiece, I will explore
the power of the human right to health in improv-
ing health generally.
Jonathan Mann rightly observed that “health





Paul Farmer has argued that “the most important





 Farmer noted that many poor peo-
ple have no access to modern medicine and con-
cluded, “The more effective the treatment, the
greater the injustice meted out to those who do




 Access to treatment for
infection with the human immunodeficiency vi-
rus (HIV) and AIDS has been problematic in most
countries, but especially in South Africa, where
almost 5 million people are infected with HIV and
the government’s attitude toward the epidemic





 Political resistance by the South African
government to outside funders who want to set
the country’s health care agenda is, of course, un-





 But even understandable politics can-
not excuse the government’s failure to act more
decisively in the face of an unprecedented epi-
demic.
One of the most controversial actions of the South
African government was its restriction of the use
of nevirapine to prevent the transmission of HIV
from mothers to infants. Only two government hos-
pitals per province were allowed to use the drug. The
Treatment Action Campaign was formed in 1998
as a coalition of South African AIDS-related organi-
zations to promote affordable treatment for all peo-
ple with HIV infection or AIDS. This group (and
others) scored a victory in 2001, when 39 multina-
tional pharmaceutical companies withdrew their
lawsuit against the South African government, which
sought to enforce their patents on drugs for the
treatment of HIV infection or AIDS, in order to pre-
vent the government from purchasing generic ver-





At about the same time, the Treatment Action
Campaign brought a suit against the South African
government itself, alleging that its restrictions on
the availability of nevirapine (limiting it in the pub-
lic sector to hospitals involved in a pilot study) and
its failure to have a reasonable plan to make the
drug more widely available violated the right to
health of HIV-positive pregnant women and their
children guaranteed in the South African constitu-
tion. The use of nevirapine remains controversial
in Africa, even after a study in Uganda, published
in 1999, suggested that administering the drug to a
pregnant woman at the onset of labor and to her
newborn immediately after birth could result in a





 This is the basis for the claim that failure to
use nevirapine condemns 35,000 newborns a year




The Treatment Action Campaign prevailed in
the trial court, which ruled that restricting nevira-
pine to a limited number of pilot sites in the public
hiv infection
and the right to health
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sector “is not reasonable and is an unjustifiable bar-





 In July 2002, the Constitutional Court
of South Africa, the country’s highest court, affirmed
the ruling, stating that the government’s nevirapine
policy violated the health care rights of women and




Section 27 of the post-apartheid constitution states,
“(1) Everyone has the right to have access to
(a) health care services, including reproductive
health care; (b) sufficient food and water; and (c) so-
cial security. . . . (2) The state must take reason-
able legislative and other measures, within its avail-
able resources, to achieve the progressive realization
of each of these rights. (3) No one may be refused
emergency medical treatment.” Section 28 states,
“(1) Every child has a right . . . (b) to family care
or parental care, or to appropriate alternative care
when removed from the family environment; (c) to
basic nutrition, shelter, basic health care services
and social services. . . . (2) A child’s best interests





These rights are part of the bill of rights in the
South African constitution, which the constitution
itself requires the state to “respect, protect, promote
and fulfill.” These provisions are modeled on those
in the International Covenant on Economic, Social
and Cultural Rights (which has been signed, but




 Under the cove-
nant, the right to health includes not only appro-
priate health care, but also the underlying determi-
nants of health, including clean water, adequate





 South Africa’s constitutional health
obligations apply to every branch of government.
The Constitutional Court considered two questions:
what actions the government was constitutionally
required to take with regard to nevirapine, and
whether the government had an obligation to es-
tablish a comprehensive plan for the prevention of
HIV transmission from mother to child.
As justification for its refusal to make nevirapine
generally available in public clinics, the South Af-
rican government has argued that the drug’s safety
and efficacy have not been satisfactorily established
and that it is of limited benefit in a breast-feeding
population (since the number of infants acquiring
HIV from breast-feeding would be almost as large
as the number infected in the absence of preventive
treatment with nevirapine). These views have been
articulated by the minister of health, who along with
President Mbeki, continues to take positions on HIV
infection and its treatment that scientists in the




In January 2001, after a meeting of southern Af-
rican countries, the World Health Organization rec-
ommended the administration of nevirapine to
HIV-positive women who are pregnant and to their
children at the time of birth. In April 2001, the Med-
icines Control Council, South Africa’s equivalent of
the Food and Drug Administration, formally ap-
proved nevirapine as safe and effective. Shortly
thereafter, in July 2001, the government decided to
do the pilot study of nevirapine that was at issue in
the lawsuit; this study limited the drug’s availability
to two sites in each province. The result was that
physicians who worked at other facilities in the pub-
lic sector were unable to prescribe this drug for their
patients, even though the manufacturer of the drug,
Boehringer Ingelheim, had agreed to make it avail-
able at no cost for a five-year period.
The Treatment Action Campaign argued that in
the face of the HIV epidemic, which includes the in-
fection of approximately 70,000 infants from their
mothers annually, it was irrational and a breach of
the bill of rights for the government to prohibit phy-
sicians in public clinics from prescribing nevirapine




This was the third case in which the Constitutional
Court had been asked to enforce a socioeconomic













 It involved a 41-year-old man with
chronic renal failure and a history of stroke, heart
disease, and diabetes, who was not eligible for a
kidney transplant and therefore required lifelong
dialysis to survive. The renal-dialysis unit in the re-
gion where he lived, which had 20 dialysis machines
— not nearly enough to provide dialysis for every-
one who required it — had a policy of accepting
only patients with acute renal failure. The health de-
partment argued that this policy met the govern-
ment’s duty to provide emergency care under the
constitution. Patients with chronic renal failure, like
the petitioner, did not automatically qualify.
In considering whether the constitution required
making nevirapine available
enforcing the obligation 
to respect rights
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the health department to provide a sufficient num-
ber of machines to offer dialysis to everyone whose
life could be saved by it, the court observed that un-
der the constitution, the state’s obligation to pro-
vide health care services was qualified by its “avail-
able resources.” The court noted that offering
extremely expensive medical treatments to every-
one would make “substantial inroads into the
health budget . . . to the prejudice of the other





tutional Court ultimately decided that the adminis-
trators of provincial health services, not the courts,
should set budgetary priorities and that the courts
should not interfere with decisions that are rational
and made “in good faith by the political organs and
medical authorities whose responsibility it is to












 a case in-
volving the right to housing, the Constitutional
Court determined that although the state is obligat-
ed to act positively to ameliorate the conditions of
the homeless, it “is not obligated to go beyond avail-





 The constitutional requirement is that the
right to housing be “progressively realized.” None-
theless, the court noted, there is “at the very least,
a negative obligation placed upon the state and all
other entities and persons to desist from prevent-





Applying the rulings in these two cases to the
nevirapine case, the Constitutional Court reason-
ably concluded that the right to health care services
“does not give rise to a self-standing and independ-
ent fulfillment right” that is enforceable irrespec-
tive of available resources. Nonetheless, the govern-
ment’s obligation to respect rights, as articulated in





The Constitutional Court reframed the two ques-
tions it would answer in the light of the South Afri-
can government’s obligation to take “reasonable
steps” for the “progressive realization” of the right
to health as follows: “Is the policy of confining the
supply of nevirapine reasonable in the circumstanc-
es; and does the government have a comprehen-





The South African government argued that the
real cost of delivering nevirapine is not the cost of
the drug but the cost of the infrastructure of care:
HIV testing, counseling, follow-up, and the provi-
sion of formula for parents who cannot currently
afford it. The Constitutional Court agreed that the
ideal is to make these preventive services universal-
ly available but restated the dispute as “whether it
was reasonable to exclude the use of nevirapine for
the treatment of mother-to-child transmission at





The South African government gave four reasons
for its restriction of the use of nevirapine: its effica-
cy would be diminished in settings in which a com-
prehensive package of services, including breast-
milk substitutes, was not available; administration
of the drug might produce a drug-resistant form of
HIV; the safety of nevirapine has not been adequate-
ly demonstrated; and the public health system does





The court addressed each point in turn. With re-
spect to efficacy, the court found that breast-feed-
ing does increase the risk of HIV infection “in some,
but not all cases and that nevirapine thus remains





 The court conceded that
drug resistance is possible but concluded, “The
prospects of the child surviving if infected are so
slim and the nature of the suffering [is] so grave that
the risk of some resistance manifesting at some





ty issue was disposed of by reference to the World
Health Organization’s recommendation of nevir-
apine and the determination of the Medicines
Control Council that the drug is safe. As for capac-
ity, the court concluded that resources are relevant
to the universal delivery of the “full package” but
are “not relevant to the question of whether nevir-
apine should be used to reduce mother-to-child
transmission of HIV at those public hospitals and
clinics outside the research sites where facilities in




This case is a right-to-health case because it con-
cerns the availability of a drug and the circumstanc-
es under which the government can reasonably re-
strict its use. Nonetheless, the case could have been
decided solely on the basis of the rights of chil-
dren. In the words of the Constitutional Court, “This
enforcing the obligation 
to protect rights
the rights of children and the
obligation to fulfill rights
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case is concerned with newborn babies whose lives
might be saved by the administration of nevira-





court specifically cites the constitutional rights of
children, including their right to “basic health care
services.” Parents have the primary obligation to
provide these services to children but often cannot




The court concluded that nevirapine is an “essen-
tial” drug for children whose mothers are infected
with HIV, that the needs of these children are “most
urgent,” and that their ability to exercise all other




 The court did not write
about the certainty of the children becoming or-
phans if their mothers do not also have access to
treatment, but treatment of HIV infection and AIDS
was beyond the scope of this case, which concerned
the prevention of HIV infection.
On the basis of either the right to health or the
rights of children, the court’s answer to the first
question was that the policy of restricting the avail-
ability of nevirapine is unreasonable and a violation
of the government’s obligation to take “reasonable
legislative and other measures, within its available
resources, to achieve the progressive realization” of
the right to “access to health care services, includ-




 In the court’s words,
“A potentially lifesaving drug was on offer and where
testing and counseling facilities were available it
could have been administered within the available





The question of whether the
cost of nevirapine mattered was not addressed, al-
though the outcome almost certainly would have
been different had nevirapine not been available at
no or very low cost.
The answer to the second question — whether
the government is required to have a reasonable,
comprehensive plan to combat mother-to-child
transmission of HIV — flowed directly from the
answer to the first. The legal question was whether
the government’s plan of moving slowly from lim-
ited research and training programs to more avail-
able programs was reasonable. The court decided
that because of the “incomprehensible calamity” of
the HIV epidemic in South Africa, the government’s
plan was not reasonable.
Can the Constitutional Court be accused of taking
on the role of the South African government’s health
department in deciding how money should be spent
on health care? The court did not think so, pointing
out that all branches of the government have the
obligation to “respect, protect, promote and fulfill”
the socioeconomic rights spelled out in the con-
stitution. The legislative branch is obligated to pass
“reasonable legislative” measures, and the executive
branch is obligated to develop and implement “ap-





is, of course, the role of the judiciary to resolve dis-
putes about whether a specific law or policy, or its
implementation, is consistent with the terms of
the constitution. Since the initiation of the nevira-
pine lawsuit, three of the country’s nine provinces
— Western Cape, Gauteng, and KwaZulu-Natal
— have publicly announced a plan to realize pro-
gressively “the rights of pregnant women and their





court expects the other six provinces to follow suit.
The court was explicit both in defining the rights
that were violated and in ordering a remedy. As to
the rights, the court declared that “Sections 27(1)
and (2) of the Constitution require the government
to devise and implement within its available resourc-
es a comprehensive and coordinated program to
realize progressively the rights of pregnant women
and their newborn children to have access to health





 To implement this right, the court ordered
the government to take four specific actions:
Remove the restrictions that prevent nevira-
pine from being made available . . . at pub-
lic hospitals and clinics that are not research
and training sites.
Permit and facilitate the use of nevirapine
. . . at public hospitals and clinics when
. . . this is medically indicated. . . .
Make provision if necessary for counselors
based at public hospitals and clinics . . . to
be trained for counseling. . . .
Take reasonable measures to extend the test-
ing and counseling facilities at hospitals and
clinics throughout the public health sector to




The decision in the nevirapine case illustrates both
the strength and the weakness of relying on courts
the right to the progressive 
realization of health implementing the right to health
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to determine specific applications of the right to
health. The strength is that the right to health is a
legal right, and since there can be no legal right
without a remedy, courts will provide a remedy for
violations of the right to health. In this regard, it
is worth noting not only that the right to health
and access to health care articulated in the Univer-
sal Declaration of Human Rights has been given
more specific meaning in the International Cove-




and other internationally binding documents on
human rights, but also that these rights have been
written into the constitutions of many countries,
including South Africa. The widespread failure of
governments to take the right to health seriously,
however, means that we are still a long way from the
realization of this right. Nonetheless, the recent ac-
tivism of many new nongovernmental organiza-
tions, such as the Treatment Action Campaign, in
the area of health rights, provides some ground for





The weakness of relying on courts is that the
subject matter of the right to health in a courtroom
struggle is likely to be narrow, involving interven-
tions such as kidney dialysis or nevirapine therapy.
The HIV epidemic demands a comprehensive strat-
egy of treatment, care, and prevention, including





 The government of South Af-
rica has so far been unwilling to designate the HIV
epidemic as a national emergency or to take steps
to make the prevention and treatment of HIV in-
fection its highest health priority. This stance has
apparently changed little since the decision on ne-
virapine was handed down. The South African gov-
ernment, for example, has asked the Medicines
Control Council to review its approval of nevirapine





 Of course, if the council withdraws its ap-
proval of the drug, this action will effectively render
the Constitutional Court’s decision moot, since its
orders are based on the finding that nevirapine is
safe and effective. On the more positive side, South
Africa’s cabinet has announced that it is considering
universal access to antiretroviral drugs, and Ran-
baxy, the largest manufacturer of generic drugs in
India, has formed a joint venture with Adcock Ingram





Former South African president Nelson Man-
dela has persuasively argued that an effective strat-
egy for combatting the AIDS epidemic requires the
engaged commitment of national leaders to provide
not only prevention but also treatment for everyone
who needs it, “wherever they may be in the world





 Lack of leadership in addressing the HIV
epidemic specifically and the right to health in gen-
eral is not, of course, confined to South Africa.
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